Carole Mievis

University of Liège, Centre Hospitalier Universitaire de Liège

Papers

Total Citations

H-Index

About

Carole Mievis is a leading figure in the field of stereotactic body radiotherapy (SBRT), with a focused expertise in the treatment of oligometastatic disease and the precise dosimetry of robotic radiosurgery systems. Her major contributions center on the clinical application of the CyberKnife platform, particularly for patients with oligorecurrent pulmonary metastases. In her highly cited 2020 work, she demonstrated the efficacy and safety of this non-invasive approach, providing critical data on local control and toxicity that has helped shape treatment paradigms for patients with limited lung metastases. Beyond clinical outcomes, Mievis has made significant technical contributions to treatment planning. Her 2017 paper on commissioning a Monte Carlo algorithm for robotic radiosurgery, which introduced a novel cylindrical 3D-array with variable density inserts, has been instrumental in improving dose calculation accuracy. This work is widely referenced by medical physicists and radiation oncologists seeking to validate and optimize their own SBRT programs. With over 38 citations across her key publications, Mievis’s research bridges the gap between advanced treatment delivery technology and tangible patient benefit, establishing her as a respected authority in the advancement of stereotactic radiosurgery.